Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Ascending Single Dose Study of Rhu-pGelsolin in Patients With Decreased Gelsolin Levels
Phase 1
Completed
- Conditions
- Low GelsolinTraumaInfectionBurns
- Interventions
- Drug: PlaceboDrug: rhu-pGelsolin
- First Posted Date
- 2008-05-05
- Last Posted Date
- 2010-09-29
- Lead Sponsor
- Critical Biologics Corporation
- Target Recruit Count
- 40
- Registration Number
- NCT00671307
- Locations
- 🇭🇰
Queen Mary Hospital; University of Hong Kong, Hong Kong, SAR, Hong Kong
News
No news found